Effects of renal denervation vs sham in resistant hypertension after medication escalation: prespecified analysis at 6 months of the RADIANCE-HTN TRIO randomized …
Importance Although early trials of endovascular renal denervation (RDN) for patients with
resistant hypertension (RHTN) reported inconsistent results, ultrasound RDN (uRDN) was
found to decrease blood pressure (BP) vs sham at 2 months in patients with RHTN taking
stable background medications in the Study of the ReCor Medical Paradise System in
Clinical Hypertension (RADIANCE-HTN TRIO) trial. Objectives To report the prespecified
analysis of the persistence of the BP effects and safety of uRDN vs sham at 6 months in …
resistant hypertension (RHTN) reported inconsistent results, ultrasound RDN (uRDN) was
found to decrease blood pressure (BP) vs sham at 2 months in patients with RHTN taking
stable background medications in the Study of the ReCor Medical Paradise System in
Clinical Hypertension (RADIANCE-HTN TRIO) trial. Objectives To report the prespecified
analysis of the persistence of the BP effects and safety of uRDN vs sham at 6 months in …
以上显示的是最相近的搜索结果。 查看全部搜索结果